Category Archives: Business of the drug industry

Senate Republicans stick it to Medicaid patients while pharma remains silent

It would be a big mistake to call the legislation Senate Republicans released on Thursday a health care bill. It is, plain and simple, a plan to cut taxes for the wealthy by destroying critical federal programs that help provide health care to tens of millions of people. Even with this charade pharma seems happy because “they got what they want” from this President. Continue reading

10 ways pharma can improve its image

top-10-listAccording to Forbes ” The 31 pharmaceutical companies comprising its main trade group spent $48.5 billion on research and development last year. All told, the pharmaceutical sector has spent $550 billion on R&D since 2000. That half-trillion dollars of research has yielded more than 400 new medicines”  But of 12 cancer drugs approved in 2012, 11 cost more than $100,000.  As more drugs are offered at that level and their sponsors get away with it, it seems to set a floor that emboldens drug companies to push the envelope.  They are badly misjudging the brewing anger. Continue reading